RAYMOND E MARIANI O.D.
Prescription History 1205831724
Optometrist in Rockville Centre, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for RAYMOND E MARIANI O.D., an active Optometrist specialist practicing in Rockville Centre, NY. Our medical registry currently tracks 20 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 751 documented patient claims. Among these therapy options, the most frequently utilized medication is Prednisolone Acetate, which accounts for 163 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| Prednisolone Acetate | 163 | $38.17▼ below NY avg | ≈ Typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 163 Medicare prescriptions for Prednisolone Acetate, about 1.2 times the volume of the typical New York prescriber of this medication (135). Medicare paid an average of $38.17 per fill, versus $52.63 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 233.1 30-Day Fills standardized to 30-day supplies 6,187 Days of Medication total across all patients in 2023 | |||
| Latanoprost | 122 | $17.30▼ below NY avg | ≈ Typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 122 Medicare prescriptions for Latanoprost, about 82% of the volume of the typical New York prescriber of this medication (149). Medicare paid an average of $17.30 per fill, versus $20.93 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 262 30-Day Fills standardized to 30-day supplies 7,700 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 75 | $35.82▼ below NY avg | ≈ Typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 75 Medicare prescriptions for Timolol Maleate, about the same volume as the typical New York prescriber of this medication (70). Medicare paid an average of $35.82 per fill, versus $38.85 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 146.4 30-Day Fills standardized to 30-day supplies 4,325 Days of Medication total across all patients in 2023 | |||
| RestasisCyclosporine | 56 | $1,240.81 | ▼ Less than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 56 Medicare prescriptions for Restasis, about 60% of the volume of the typical New York prescriber of this medication (93). Medicare paid an average of $1,240.81 per fill, versus $1,034.99 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 108 30-Day Fills standardized to 30-day supplies 3,240 Days of Medication total across all patients in 2023 | |||
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 43 | $12.44▼ below NY avg | ≈ Typical |
About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾ This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2023, this provider wrote 43 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about 88% of the volume of the typical New York prescriber of this medication (49). Medicare paid an average of $12.44 per fill, versus $14.55 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 43 30-Day Fills standardized to 30-day supplies 509 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 42 | $20.74▼ below NY avg | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 42 Medicare prescriptions for Dorzolamide-Timolol, about half the volume of the typical New York prescriber of this medication (90). Medicare paid an average of $20.74 per fill, versus $32.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 84.4 30-Day Fills standardized to 30-day supplies 2,530 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 24 | $93.36 | ▼ Less than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 24 Medicare prescriptions for Brimonidine Tartrate, about a third of the volume of the typical New York prescriber of this medication (61). Medicare paid an average of $93.36 per fill, versus $70.70 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 32.7 30-Day Fills standardized to 30-day supplies 915 Days of Medication total across all patients in 2023 | |||
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 24 | $60.24▼ below NY avg | ▼ Less than typical |
About Tobramycin-Dexamethasone: This medication is used to treat or prevent eye infections. Show more ▾ This medication contains two drugs. Tobramycin belongs to a class of drugs called aminoglycoside antibiotics. It works by stopping the growth of bacteria. Dexamethasone belongs to a class of drugs called corticosteroids. It works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A topical preparation of tobramycin and dexamethasone that is used for treating or preventing superficial bacterial infections of the eye. In 2023, this provider wrote 24 Medicare prescriptions for Tobramycin-Dexamethasone, about half the volume of the typical New York prescriber of this medication (41). Medicare paid an average of $60.24 per fill, versus $81.44 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 25.3 30-Day Fills standardized to 30-day supplies 549 Days of Medication total across all patients in 2023 | |||
| Brinzolamide | 23 | $272.29▼ below NY avg | ▼ Less than typical |
About Brinzolamide: Brinzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 23 Medicare prescriptions for Brinzolamide, about 74% of the volume of the typical New York prescriber of this medication (31). Medicare paid an average of $272.29 per fill, versus $343.65 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 42.7 30-Day Fills standardized to 30-day supplies 1,280 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 22 | $25.25▼ below NY avg | ▼ Less than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 22 Medicare prescriptions for Dorzolamide Hcl, about half the volume of the typical New York prescriber of this medication (48). Medicare paid an average of $25.25 per fill, versus $30.75 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 48.3 30-Day Fills standardized to 30-day supplies 1,430 Days of Medication total across all patients in 2023 | |||
| Loteprednol Etabonate | 22 | $177.32▼ below NY avg | ▼ Less than typical |
About Loteprednol Etabonate: This medication is used to temporarily relieve seasonal allergy symptoms of the eyes such as swelling, redness, and itching. Show more ▾ Loteprednol belongs to a class of drugs known as corticosteroids. An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions. In 2023, this provider wrote 22 Medicare prescriptions for Loteprednol Etabonate, about 67% of the volume of the typical New York prescriber of this medication (33). Medicare paid an average of $177.32 per fill, versus $214.23 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 37.1 30-Day Fills standardized to 30-day supplies 1,013 Days of Medication total across all patients in 2023 | |||
| CombiganBrimonidine Tartrate/Timolol | 20 | $390.04▼ below NY avg | ▼ Less than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 20 Medicare prescriptions for Combigan, about a third of the volume of the typical New York prescriber of this medication (52). Medicare paid an average of $390.04 per fill, versus $403.34 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 34.2 30-Day Fills standardized to 30-day supplies 995 Days of Medication total across all patients in 2023 | |||
| Travoprost | 18 | $348.27 | ▼ Less than typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 18 Medicare prescriptions for Travoprost, about half the volume of the typical New York prescriber of this medication (35). Medicare paid an average of $348.27 per fill, versus $266.95 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 45.3 30-Day Fills standardized to 30-day supplies 1,353 Days of Medication total across all patients in 2023 | |||
| Ofloxacin | 18 | $17.40▼ below NY avg | ▼ Less than typical |
About Ofloxacin: This medication is used to treat eye infections. Show more ▾ Ofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. In 2023, this provider wrote 18 Medicare prescriptions for Ofloxacin, about a quarter of the volume of the typical New York prescriber of this medication (73). Medicare paid an average of $17.40 per fill, versus $20.90 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 20.1 30-Day Fills standardized to 30-day supplies 462 Days of Medication total across all patients in 2023 | |||
| FlarexFluorometholone Acetate | 17 | $167.56 | ▼ Less than typical |
About Flarex: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Fluorometholone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 17 Medicare prescriptions for Flarex, about a third of the volume of the typical New York prescriber of this medication (52). Medicare paid an average of $167.56 per fill, versus $136.83 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 38.3 30-Day Fills standardized to 30-day supplies 1,102 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 16 | $546.06 | ▼ Less than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 16 Medicare prescriptions for Lumigan, about a quarter of the volume of the typical New York prescriber of this medication (77). Medicare paid an average of $546.06 per fill, versus $492.27 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 37.5 30-Day Fills standardized to 30-day supplies 1,105 Days of Medication total across all patients in 2023 | |||
| XiidraLifitegrast | 12 | $1,335.44 | ▼ Less than typical |
About Xiidra: This medication is used to treat dry eye disease. In 2023, this provider wrote 12 Medicare prescriptions for Xiidra, about a quarter of the volume of the typical New York prescriber of this medication (50). Medicare paid an average of $1,335.44 per fill, versus $945.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2023 | |||
| SimbrinzaBrinzolamide/Brimonidine Tart | 12 | $205.06▼ below NY avg | ▼ Less than typical |
About Simbrinza: This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Show more ▾ Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists. This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. In 2023, this provider wrote 12 Medicare prescriptions for Simbrinza, about a third of the volume of the typical New York prescriber of this medication (34). Medicare paid an average of $205.06 per fill, versus $261.48 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 17.9 30-Day Fills standardized to 30-day supplies 535 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 11 | $109.62▼ below NY avg | ▼ Less than typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 11 Medicare prescriptions for Brimonidine Tartrate-Timolol, about half the volume of the typical New York prescriber of this medication (24). Medicare paid an average of $109.62 per fill, versus $303.99 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 12.3 30-Day Fills standardized to 30-day supplies 323 Days of Medication total across all patients in 2023 | |||
| Alphagan PBrimonidine Tartrate | 11 | $214.97▼ below NY avg | ▼ Less than typical |
About Alphagan P: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 11 Medicare prescriptions for Alphagan P, about a quarter of the volume of the typical New York prescriber of this medication (49). Medicare paid an average of $214.97 per fill, versus $396.46 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 11.7 30-Day Fills standardized to 30-day supplies 305 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for RAYMOND E MARIANI O.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Rockville Centre, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NY prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
